Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
(53 sites) United States
University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham, Alabama Finlay Medical Research- Site Number : 8400010, Miami, Florida Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore, Maryland American Health Research - Charlotte- Site Number : 8400013, Charlotte, North Carolina Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem, North Carolina Clinical Research Associates of Central PA- Site Number : 8400002, DuBois, Pennsylvania REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont, Texas Argentina
Investigational Site Number : 0320001, San Miguel de Tucumán, Tucumán Province Investigational Site Number : 0320002, Buenos Aires Investigational Site Number : 0320003, Buenos Aires Brazil
Associacao Proar- Site Number : 0760005, Salvador, Estado de Bahia Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760002, Porto Alegre, Rio Grande do Sul Hospital Beneficência Portuguesa de São Paulo- Site Number : 0760006, São Paulo Incor - Instituto do Coracao- Site Number : 0760001, São Paulo China
Investigational Site Number : 1560001, Guangzhou Denmark
Investigational Site Number : 2080003, Aalborg Investigational Site Number : 2080002, Vejle France
Investigational Site Number : 2500008, La Tronche Investigational Site Number : 2500001, Lille Investigational Site Number : 2500005, Lyon Investigational Site Number : 2500006, Marseille Investigational Site Number : 2500002, Montpellier Investigational Site Number : 2500003, Pessac Investigational Site Number : 2500004, Reims Hungary
Investigational Site Number : 3480003, Debrecen Investigational Site Number : 3480001, Hajdúnánás Investigational Site Number : 3480002, Pécs Italy
Investigational Site Number : 3800001, Cona, Ferrara Investigational Site Number : 3800004, Siena Netherlands
Investigational Site Number : 5280001, Groningen Investigational Site Number : 5280003, Hoofddorp Investigational Site Number : 5280006, Nijmegen Poland
Investigational Site Number : 6160001, Poznan, Greater Poland Voivodeship Investigational Site Number : 6160003, Bialystok, Podlaskie Voivodeship Investigational Site Number : 6160002, Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship South Korea
Investigational Site Number : 4100005, Anyang-si, Gyeonggi-do Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100004, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi Investigational Site Number : 4100003, Seoul, Seoul-teukbyeolsi Spain
Investigational Site Number : 7240001, Barcelona, Barcelona [Barcelona] Investigational Site Number : 7240005, Santander, Cantabria Investigational Site Number : 7240002, Pozuelo de Alarcón, Madrid Investigational Site Number : 7240004, Oviedo, Principality of Asturias Investigational Site Number : 7240003, Madrid Sweden
Investigational Site Number : 7520002, Gothenburg Investigational Site Number : 7520003, Lund Taiwan
Investigational Site Number : 1580001, Kaohsiung City Investigational Site Number : 1580002, Taipei United Kingdom
Investigational Site Number : 8260006, Newcastle upon Tyne, England Investigational Site Number : 8260008, Southampton, Hampshire Investigational Site Number : 8260003, Leicester, Leicestershire Investigational Site Number : 8260001, Bradford